Trial intelligence / Profile preview

Lorcaserin in Smokers With Alcohol Use Disorder

NCT04396847Phase 2Terminated

Sponsor
The Mind Research Network
Start
Oct 2019
Primary completion
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of lorcaserin in alcohol use disorder (AUD), Tobacco Use Disorder (TUD), sponsored by The Mind Research Network. Started Oct 2019; status: terminated.

02

Drugs

lorcaserin
03

Conditions

alcohol use disorder (AUD)Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT04396847.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04396847.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call